Essenvia
PrivateLast Round
Series A
Nov 15, 2023
Total Funding Raised
$4M
Company Overview
Essenvia is a health-tech company that provides an AI-powered regulatory information management platform to streamline medical device regulatory submissions and lifecycle management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, RegTech, Compliance, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Essenvia Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Essenvia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 15, 2023 | ||||
| Seed | May 2, 2023 |
Essenvia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wavemaker Three-Sixty Health | Seed |
| Rebright Partners | Seed |
| Pasadena Angels | Seed |
| First Rays Venture Partners | Seed |
| Benhamou Global Ventures | Seed |
Essenvia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Essenvia's valuation, stock price, and market status.